Utilization of the herpes simplex virus type 1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system.
about
A novel Cre recombinase imaging system for tracking lymphotropic virus infection in vivo.Interferon alpha induces establishment of alphaherpesvirus latency in sensory neurons in vitro.Long-term transgene expression in mice infected with a herpes simplex virus type 1 mutant severely impaired for immediate-early gene expression.Pseudotyping of glycoprotein D-deficient herpes simplex virus type 1 with vesicular stomatitis virus glycoprotein G enables mutant virus attachment and entry.Evidence for a bidirectional element located downstream from the herpes simplex virus type 1 latency-associated promoter that increases its activity during latencyAnalysis of protein expression from within the region encoding the 2.0-kilobase latency-associated transcript of herpes simplex virus type 1Tracking the spread of a lacZ-tagged herpes simplex virus type 1 between the eye and the nervous system of the mouse: comparison of primary and recurrent infectionA historical analysis of herpes simplex virus promoter activation in vivo reveals distinct populations of latently infected neuronesHSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applicationsMeganuclease-mediated Inhibition of HSV1 Infection in Cultured Cells.PrP(c) expression influences the establishment of herpes simplex virus type 1 latency.Herpes simplex virus type 1 latently infected neurons differentially express latency-associated and ICP0 transcripts.Herpes simplex virus-based vectors.Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation.The HSV-1 Latency-Associated Transcript Functions to Repress Latent Phase Lytic Gene Expression and Suppress Virus Reactivation from Latently Infected NeuronsInfluence of herpes simplex virus 1 latency-associated transcripts on the establishment and maintenance of latency in the ROSA26R reporter mouse modelAn investigation of herpes simplex virus promoter activity compatible with latency establishment reveals VP16-independent activation of immediate-early promoters in sensory neuronesDevelopment and pathogenic evaluation of recombinant herpes simplex virus type 1 expressing two fluorescent reporter genes from different lytic promotersA 16 bp upstream sequence from the rat tyrosine hydroxylase promoter supports long-term expression from a neurofilament promoter, in a helper virus-free HSV-1 vector system.Expression of the herpes simplex virus type 1 latency-associated transcripts does not influence latency establishment of virus mutants deficient for neuronal replication.An enhanced packaging system for helper-dependent herpes simplex virus vectors.Development and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral nervous system.Herpes simplex virus type 1 promoter activity during latency establishment, maintenance, and reactivation in primary dorsal root neurons in vitro.De Novo Herpes Simplex Virus VP16 Expression Gates a Dynamic Programmatic Transition and Sets the Latent/Lytic Balance during Acute Infection in Trigeminal Ganglia.Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo.
P2860
Q33490133-2009A360-555E-49A0-B8D2-EB871D861678Q33711923-C8245ED3-F862-4538-8CFE-68A6CFAF98D8Q33796629-8BD01357-F388-43AC-A2D7-FE31875592B8Q33799437-99D37A07-74DA-4F01-9E9A-AAC211C48DD6Q33802267-B42356D0-C78F-49EE-A985-C49A19DC5235Q33838578-B586BD78-6ACA-48CB-9397-DB0563D464F5Q33851936-07F36153-DF2E-43D2-9112-4915C2443FDDQ33910593-6B38AC0F-2E19-4549-AEA1-E92D00AC9F61Q33995752-0A4BE6DF-0DA0-4F0E-8046-52A7E59272F0Q34757252-EFF3212C-3D77-4D71-A7BB-21B5059F926AQ34969580-C6950084-AA1A-4AC4-B172-7FA129FDD44BQ35024312-C4E843DF-D237-437E-87A0-B072ED4BDBDCQ35863367-331891FE-9BFC-4CAA-BA51-48231A2B2402Q35935558-9C4CABF9-5C8B-4D68-910D-0484F4BB879FQ35982911-27A2D2A6-A242-4460-A201-34E47188A7DBQ36172119-A594B712-8276-4A8B-9290-B1A1F6D6AAD3Q36523264-348F9F10-8996-4D80-814A-106E782F3355Q37037000-ED7D4DD7-9E2F-483E-B5A1-C934D4F17763Q38669532-3AA2C486-15D0-4D61-9155-7FACD611410CQ39116863-24779092-D199-4D20-A76D-D8BA05A336D9Q39580097-E326110F-2303-4579-BBB6-B36E5497C029Q39591444-750A9AF0-4845-487A-9061-6157243579FEQ39605992-3643E0F9-6A74-4BDE-85E5-5379DC8B45DBQ40547302-04EEAA3E-86CD-49A9-9463-849B02B384F5Q40814855-EF19735C-73B3-4468-A6F9-66E1E8311AD5
P2860
Utilization of the herpes simplex virus type 1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Utilization of the herpes simp ...... ression in the nervous system.
@ast
Utilization of the herpes simp ...... ression in the nervous system.
@en
type
label
Utilization of the herpes simp ...... ression in the nervous system.
@ast
Utilization of the herpes simp ...... ression in the nervous system.
@en
prefLabel
Utilization of the herpes simp ...... ression in the nervous system.
@ast
Utilization of the herpes simp ...... ression in the nervous system.
@en
P2860
P1433
P1476
Utilization of the herpes simp ...... pression in the nervous system
@en
P2093
Efstathiou S
P2860
P304
P407
P577
1997-04-01T00:00:00Z